USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Abiomed Europe Gmbh

USPTO PatentsView assignee record - 91 granted patents across 13 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

18.4

Avg claims per patent

+558%

5-year filing velocity

The verdict

Abiomed holds 91 US patents across 13 technology areas, rank #3,952 of 50,000 tracked assignees.

#3,952
of 50,000 US assignees by volume: Top 10%
by Innovation Score (52.5/100): 18.4
avg claims per patent: +558%
filing velocity, last 5 yrs

Portfolio overview

Abiomed Europe Gmbh has been granted 91 US utility patents between 2016 and 2025, placing Abiomed Europe Gmbh at rank #3,952 across all assignees tracked by PlainPatent. This portfolio spans 13 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.4 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a Foreign Corporation, Abiomed Europe Gmbh is one of the more focused assignees in the PatentsView dataset. By volume, Abiomed sits between Veeco Instruments Inc. (92 patents, rank #3,948) and Board Of Trustees Of Southern Illinois University (91 patents, rank #3,956) - the closest US assignees by grant volume. The composite Innovation Score of 52.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 79 grants, compared with 12 in the 2015–2019 window, a +558% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Abiomed Europe Gmbh's 18.4 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 13 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Abiomed Europe Gmbh against peers pursuing similar technology classes.

Veeco Instruments

92
Videojet

92
Watts Regulator

92
Willis Electric

92
Agios Pharmaceuti…

91
Anhui Huami Infor…

91
Azur Space Solar…

91
Board of Trustees…

91
Abiomed Europe ◀

91

What this shows Abiomed holds 91 patents at rank #3,952, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Abiomed

By rank, the assignees closest to #3,952 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media INTO)

Other assignees with the most granted patents in Abiomed's primary technology class.

Abiomed's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

52 Top 10% higher than 90% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Abiomed Europe Gmbh patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	3	3.3%
2017	6	6.6%
2018	2	2.2%
2019	1	1.1%
2020	9	9.9%
2021	11	12.1%
2022	9	9.9%
2023	17	18.7%
2024	15	16.5%
2025	18	19.8%

Which technologies does Abiomed Europe Gmbh patent most?

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 87

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 8

F04D - NON-POSITIVE-DISPLACEMENT PUMPS 6

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 4

H01F - MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES 3

F16C - SHAFTS; FLEXIBLE SHAFTS; ELEMENTS OR CRANKSHAFT MECHANISMS; ROTARY BODIES OTHER THAN GEARING ELEMENTS; BEARINGS 2

H02K - DYNAMO-ELECTRIC MACHINES 2

B29D - PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE 1

G01L - MEASURING FORCE, STRESS, TORQUE, WORK, MECHANICAL POWER, MECHANICAL EFFICIENCY, OR FLUID PRESSURE 1

C23C - COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL 1

B29L - INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES 1

B29C - SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING 1

B29K - INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR ; MOULDS, ; REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS 1

Top 13 of 13 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Standard

Velocity Accelerating

Where it ranks

Overall rank by patents

#3,952

Across all tracked assignees

Innovation Score

52.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Abiomed Europe Gmbh hold?

Abiomed Europe Gmbh holds 91 US granted patents filed between 2016 and 2025, spanning 13 technology areas.

What is Abiomed Europe Gmbh's Innovation Score?

Abiomed Europe Gmbh has an Innovation Score of 52.5 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Abiomed Europe Gmbh focus on?

Abiomed Europe Gmbh's top technology area is A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR) with 87 patents. The company has filed patents in 13 CPC subclasses total.

Is Abiomed Europe Gmbh's patent filing rate increasing or decreasing?

Abiomed Europe Gmbh's recent filing velocity is +558% compared to the prior five-year period. This indicates accelerating innovation.

What does claim depth mean for Abiomed Europe Gmbh's patents?

Abiomed Europe Gmbh's patents average 18.4 claims each. This falls within the standard range, providing solid legal coverage.

How is the Abiomed Europe Gmbh patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Abiomed's 91 grants land it in the top 10% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Abiomed ranks #3,952 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61M - see who else leads that technology area. A61M leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.